Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease☆
References (20)
- et al.
Effects of intravenous magensium sulphate on arrhythmias in patients with congestive heart failure
Am Heart J
(1993) - et al.
Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease
Am J Cardiol
(1993) - et al.
Catecholamine-mediated constrictor effects of aldosterone on vascular smooth muscle
Life Sci
(1982) - et al.
Ectopic arrhythmia provoking action of aldosterone
Life Sci
(1962) - et al.
Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism
J Mol Cell Cardiol
(1993) - et al.
Iodine-123 metaiodobenzyleguanidine scintigraphy: a non-invasive method to demonstrate myocardial adrenergic system disintegrity in patients with idiopathic dilated cardiomyopathy
J Am Coll Cardiol
(1988) - et al.
The Randomised Aldactone Evaluation Study (RALES): parallel dose finding trial (abstr)
J Am Coll Cardiol
(1995) - et al.
Captopril in heart failure: a double-blind controlled trial
Br Heart J
(1984) - et al.
Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites
Miner Electrolyte Metab
(1993) - et al.
Interactions of mineralocorticoids and pressor agents in vascular smooth muscle
Hypertension
(1983)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
This study was supported by the British Heart Foundation (London, United Kingdom) and the Scottish Hospitals Endowment Research Trust (Edinburgh, United Kingdom).
Copyright © 1995 Published by Elsevier Inc.